Skip to content
FY'25FY'24
Revenue, net by Product
MIPLYFFA$87.4M+765%$10.1M
OLPRUVA$800K+300%$200K
Segment long-lived assets by Geography
Europe$1.6M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Zevra Therapeutics, Inc. break its business down?
Zevra Therapeutics, Inc. (ZVRA) reports revenue, net by product across 2 parts — MIPLYFFA and OLPRUVA. Each is extracted from the segment footnotes and tracked over time.
Where does Zevra Therapeutics, Inc.'s segment data come from?
Segment breakdowns are pulled from the segment footnotes in Zevra Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.